As a second in vivo step in demonstrating the feasibility of using ICG as a control imaging agent, the optimized combined solution of albumin, ICG, and fluorescent antibody (see in vitro results below) was injected into the footpads of tumor-bearing rats (n = 4 with IRDye 700DX-cetuximab + ICG + albumin). Here, ALB is linked to neoplasm.